uniQure
uniQure is a leading gene therapy company dedicated to developing potentially curative, one-time treatments for severe genetic diseases.
Company facts
- Founded
- 1998
- Employees
- 200
- Headquarters
- Netherlands
- Type
- Small Business
About
uniQure is a leading gene therapy company dedicated to developing potentially curative, one-time treatments for severe genetic diseases. Utilizing a validated and modular technology platform, uniQure focuses on delivering innovative therapies to address significant unmet medical needs. The company’s pipeline includes programs targeting Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Fabry Disease, and certain forms of Epilepsy, leveraging adeno-associated virus (AAV) vector technology. uniQure offers a dynamic and impactful environment for professionals seeking to contribute to the advancement of groundbreaking therapies and improve patient lives.